{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T22:09:01Z","timestamp":1782857341926,"version":"3.54.5"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Growth Hormone & IGF Research"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.ghir.2026.101719","type":"journal-article","created":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T14:38:31Z","timestamp":1782052711000},"page":"101719","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Real world data on rhIGF-1 therapy in children with severe primary IGF-I deficiency \u2013 The European experience"],"prefix":"10.1016","volume":"85","author":[{"given":"Jannette","family":"Saavedra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Bang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ghir.2026.101719_bb0005","first-page":"152","article-title":"Genetic pituitary dwarfism with high serum concentation of growth hormone - a new inborn error of metabolism?","volume":"2","author":"Laron","year":"1966","journal-title":"Isr. J. Med. Sci."},{"issue":"4","key":"10.1016\/j.ghir.2026.101719_bb0010","first-page":"883","article-title":"Pituitary dwarfism with high serum levels of growth hormone","volume":"4","author":"Laron","year":"1968","journal-title":"Isr. J. Med. Sci."},{"issue":"1","key":"10.1016\/j.ghir.2026.101719_bb0015","first-page":"8","article-title":"Defect of human growth hormone receptors in the liver of two patients with Laron-type dwarfism","volume":"20","author":"Eshet","year":"1984","journal-title":"Isr. J. Med. Sci."},{"key":"10.1016\/j.ghir.2026.101719_bb0020","series-title":"lessons from Laron syndrome (LS) 1966-1992","first-page":"61","article-title":"Psychosocial adaptation of Ecuadorian patients with growth hormone receptor deficiency\/Laron syndrome","volume":"24","author":"Guevara Aguirre","year":"1993"},{"issue":"2","key":"10.1016\/j.ghir.2026.101719_bb0025","first-page":"417","article-title":"Growth hormone receptor deficiency in Ecuador: clinical and biochemical phenotype in two populations","volume":"76","author":"Guevara-Aguirre","year":"1993","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"20","key":"10.1016\/j.ghir.2026.101719_bb0030","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1056\/NEJM199011153232002","article-title":"The little women of Loja--growth hormone-receptor deficiency in an inbred population of southern Ecuador","volume":"323","author":"Rosenbloom","year":"1990","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ghir.2026.101719_bb0035","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ghir.2015.08.001","article-title":"A half-century of studies of growth hormone insensitivity\/Laron syndrome: a historical perspective","volume":"28","author":"Rosenbloom","year":"2016","journal-title":"Growth Hormon. IGF Res."},{"issue":"4","key":"10.1016\/j.ghir.2026.101719_bb0040","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1210\/er.2010-0023","article-title":"Evidence for a continuum of genetic, phenotypic, and biochemical abnormalities in children with growth hormone insensitivity","volume":"32","author":"David","year":"2011","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.ghir.2026.101719_bb0045","series-title":"Endotext [Internet]","article-title":"Pediatric implications of normal insulin-GH-IGF axis physiology","author":"Bang","year":"2000"},{"issue":"3","key":"10.1016\/j.ghir.2026.101719_bb0050","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1210\/edrv-15-3-369","article-title":"Growth hormone (GH) insensitivity due to primary GH receptor deficiency","volume":"15","author":"Rosenfeld","year":"1994","journal-title":"Endocr. Rev."},{"issue":"8804","key":"10.1016\/j.ghir.2026.101719_bb0055","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/0140-6736(92)91594-X","article-title":"Effects of insulin-like growth factor on linear growth, head circumference, and body fat in patients with Laron-type dwarfism","volume":"339","author":"Laron","year":"1992","journal-title":"Lancet Lond Engl."},{"issue":"1","key":"10.1016\/j.ghir.2026.101719_bb0060","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s11154-020-09603-3","article-title":"Genetic causes of growth hormone insensitivity beyond GHR","volume":"22","author":"Hwa","year":"2021","journal-title":"Rev. Endocr. Metab. Disord."},{"issue":"1","key":"10.1016\/j.ghir.2026.101719_bb0065","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1186\/s13023-023-02928-7","article-title":"Challenges in the care of individuals with severe primary insulin-like growth factor-I deficiency (SPIGFD): an international, multi-stakeholder perspective","volume":"18","author":"Backeljauw","year":"2023","journal-title":"Orphanet J. Rare Dis."},{"issue":"4","key":"10.1016\/j.ghir.2026.101719_bb0070","first-page":"364","article-title":"Growth hormone therapy: emerging dilemmas","volume":"8","author":"Laron","year":"2011","journal-title":"Pediatr. Endocrinol. Rev."},{"issue":"58","key":"10.1016\/j.ghir.2026.101719_bb0075","article-title":"Impact of short stature on quality of life: a systematic literature review","volume":"57","author":"Backeljauw","year":"2021","journal-title":"Growth Hormon. IGF Res."},{"issue":"2","key":"10.1016\/j.ghir.2026.101719_bb0080","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2019-231737","article-title":"Branding of subjects affected with genetic syndromes of severe short stature in developing countries","volume":"13","author":"Guevara-Aguirre","year":"2020","journal-title":"BMJ Case Rep."},{"issue":"5","key":"10.1016\/j.ghir.2026.101719_bb0085","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1159\/000371798","article-title":"Effectiveness and safety of rhIGF-1 therapy in children: the European Increlex\u00ae growth forum database experience","volume":"83","author":"Bang","year":"2015","journal-title":"Horm. Res. Paediatr."},{"key":"10.1016\/j.ghir.2026.101719_bb0090","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.812568","article-title":"Pubertal timing and growth dynamics in children with severe primary IGF-1 deficiency: results from the European Increlex\u00ae growth forum database registry","volume":"13","author":"Bang","year":"2022","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.ghir.2026.101719_bb0095","author":"European Medicines Agency (EMA)"},{"key":"10.1016\/j.ghir.2026.101719_bb0100","author":"Food and Drug Administration (FDA)"},{"issue":"2","key":"10.1016\/j.ghir.2026.101719_bb0105","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1530\/EJE-20-0325","article-title":"Effectiveness and safety of rhIGF1 therapy in patients with or without Laron syndrome","volume":"184","author":"Bang","year":"2021","journal-title":"Eur. J. Endocrinol."},{"issue":"1","key":"10.1016\/j.ghir.2026.101719_bb0110","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1210\/clinem\/dgad479","article-title":"Frequency and predictive factors of hypoglycemia in patients treated with rhIGF-1: data from the Eu-IGFD registry","volume":"109","author":"Bang","year":"2023","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2026.101719_bb0115","first-page":"dgaf390","article-title":"Near-adult height outcomes in patients treated with rhIGF-1 for severe growth failure: real-world IGFD registry data","author":"Ramon-Krauel","year":"2025","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.ghir.2026.101719_bb0120","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1159\/000330410","volume":"76","author":"Ekstr\u00f6m","year":"2011","journal-title":"Horm. Res. Paediatr."},{"key":"10.1016\/j.ghir.2026.101719_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.ghir.2026.101679","article-title":"The growth plate: zonal architecture, plasticity, and endocrine control of linear growth","volume":"83","author":"Ostria","year":"2026","journal-title":"Growth Hormon. IGF Res."},{"issue":"3","key":"10.1016\/j.ghir.2026.101719_bb0130","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1515\/JPEM.1995.8.3.149","article-title":"Three year IGF-I treatment of children with Laron syndrome","volume":"8","author":"Klinger","year":"1995","journal-title":"J. Pediatr. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.ghir.2026.101719_bb0135","first-page":"1393","article-title":"A randomized, double blind, placebo-controlled trial on safety and efficacy of recombinant human insulin-like growth factor-I in children with growth hormone receptor deficiency","volume":"80","author":"Guevara-Aguirre","year":"1995","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"10.1016\/j.ghir.2026.101719_bb0140","first-page":"253","article-title":"Insulin-like growth factor I improves height in growth hormone insensitivity: two years\u2019 results","volume":"44","author":"Ranke","year":"1995","journal-title":"Horm. Res."},{"issue":"3","key":"10.1016\/j.ghir.2026.101719_bb0145","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1210\/jc.2006-1610","article-title":"Long-term treatment with recombinant insulin-like growth factor (IGF)-I in children with severe IGF-I deficiency due to growth hormone insensitivity","volume":"92","author":"Chernausek","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.ghir.2026.101719_bb0150","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1210\/jc.2009-0570","article-title":"Recombinant insulin-like growth factor (IGF)-I treatment in short children with low IGF-I levels: first-year results from a randomized clinical trial","volume":"95","author":"Midyett","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.ghir.2026.101719_bb0155","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/humu.1380010105","article-title":"Mutation creating a new splice site in the growth hormone receptor genes of 37 Ecuadorean patients with Laron syndrome","volume":"1","author":"Berg","year":"1992","journal-title":"Hum. Mutat."},{"issue":"2","key":"10.1016\/j.ghir.2026.101719_bb0160","first-page":"629","article-title":"Two-year treatment of growth hormone (GH) receptor deficiency with recombinant insulin-like growth factor I in 22 children: comparison of two dosage levels and to GH-treated GH deficiency","volume":"82","author":"Guevara-Aguirre","year":"1997","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.ghir.2026.101719_bb0165","first-page":"273","article-title":"Hormonal and metabolic effects and pharmacokinetics of recombinant insulin-like growth factor-I in growth hormone receptor deficiency\/Laron syndrome","volume":"77","author":"Vaccarello","year":"1993","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.ghir.2026.101719_bb0170","first-page":"68","article-title":"Decreased ternary complex formation and predominance of a 29 kDa IGFBP-3 fragment in human fetal serum","volume":"4","author":"Bang","year":"1994","journal-title":"Growth Regul."},{"issue":"4","key":"10.1016\/j.ghir.2026.101719_bb0175","doi-asserted-by":"crossref","first-page":"363","DOI":"10.15252\/emmm.201506106","article-title":"Mutations in pregnancy-associated plasma protein A2 cause short stature due to low IGF-I availability","volume":"8","author":"Dauber","year":"2016","journal-title":"EMBO Mol. Med."},{"issue":"Suppl. 1","key":"10.1016\/j.ghir.2026.101719_bb0180","first-page":"259","article-title":"Experience with insulin-like growth factor I (IGF-I) treatment of growth hormone insensitivity syndrome (GHIS)","volume":"12","author":"Ranke","year":"1999","journal-title":"J. Pediatr. Endocrinol. Metab."},{"issue":"12","key":"10.1016\/j.ghir.2026.101719_bb0185","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1038\/s41436-021-01287-7","article-title":"Safe and persistent growth-promoting effects of vosoritide in children with achondroplasia: 2-year results from an open-label, phase 3 extension study","volume":"23","author":"Savarirayan","year":"2021","journal-title":"Genet. Med."},{"issue":"2","key":"10.1016\/j.ghir.2026.101719_bb0190","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1210\/jc.2012-3704","article-title":"Recommended IGF-I dosage causes greater fat accumulation and osseous maturation than lower dosage and may compromise long-term growth effects","volume":"98","author":"Guevara-Aguirre","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.ghir.2026.101719_bb0195","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1159\/000351958","article-title":"Adult and near-adult height in patients with severe insulin-like growth factor-I deficiency after long-term therapy with recombinant human insulin-like growth factor-I","volume":"80","author":"Backeljauw","year":"2013","journal-title":"Horm. Res. Paediatr."},{"issue":"1","key":"10.1016\/j.ghir.2026.101719_bb0200","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1210\/en.2004-0485","article-title":"Stimulation of steroidogenesis in immature rat Leydig cells evoked by interleukin-1alpha is potentiated by growth hormone and insulin-like growth factors","volume":"146","author":"Col\u00f3n","year":"2005","journal-title":"Endocrinology"},{"issue":"3","key":"10.1016\/j.ghir.2026.101719_bb0205","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1210\/endo.139.3.5852","article-title":"Insulin-like growth factor-I effects on gonadotropin-releasing hormone biosynthesis in GT1-7 cells","volume":"139","author":"Longo","year":"1998","journal-title":"Endocrinology"},{"issue":"5","key":"10.1016\/j.ghir.2026.101719_bb0210","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1210\/en.2013-1682","article-title":"Insulin-like growth factor-I regulates LH release by modulation of kisspeptin and NMDA-mediated neurotransmission in young and middle-aged female rats","volume":"155","author":"Neal-Perry","year":"2014","journal-title":"Endocrinology"},{"issue":"Suppl. 1","key":"10.1016\/j.ghir.2026.101719_bb0215","first-page":"231","article-title":"Natural history of the classical form of primary growth hormone (GH) resistance (Laron syndrome)","volume":"12","author":"Laron","year":"1999","journal-title":"J. Pediatr. Endocrinol. Metab."},{"issue":"Suppl. 1","key":"10.1016\/j.ghir.2026.101719_bb0220","first-page":"188","article-title":"Development and biological function of the female gonads and genitalia in IGF-I deficiency -- Laron syndrome as a model","volume":"3","author":"Laron","year":"2006","journal-title":"Pediatr. Endocrinol. Rev."},{"issue":"3","key":"10.1016\/j.ghir.2026.101719_bb0225","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1210\/jc.2004-1303","article-title":"Testosterone blunts feedback inhibition of growth hormone secretion by experimentally elevated insulin-like growth factor-I concentrations","volume":"90","author":"Veldhuis","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.ghir.2026.101719_bb0230","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1365-2605.2005.00556.x","article-title":"Pubertal development in Danish children: comparison of recent European and US data","volume":"29","author":"Juul","year":"2006","journal-title":"Int. J. Androl."},{"issue":"220","key":"10.1016\/j.ghir.2026.101719_bb0235","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1136\/adc.41.220.613","article-title":"Standards from birth to maturity for height, weight, height velocity, and weight velocity: British children, 1965. Part II","volume":"41","author":"Tanner","year":"1966","journal-title":"Arch. Dis. Child."},{"issue":"6","key":"10.1016\/j.ghir.2026.101719_bb0240","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1136\/adc.68.6.768","article-title":"Growth curves for Laron syndrome","volume":"68","author":"Laron","year":"1993","journal-title":"Arch. Dis. Child."},{"issue":"10","key":"10.1016\/j.ghir.2026.101719_bb0245","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1172\/JCI119438","article-title":"Hypoglycemic effect of insulin-like growth factor-1 in mice lacking insulin receptors","volume":"99","author":"Di Cola","year":"1997","journal-title":"J. Clin. Invest."},{"issue":"9","key":"10.1016\/j.ghir.2026.101719_bb0250","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.2337\/diab.39.9.1028","article-title":"IGF-I--stimulated glucose transport in human skeletal muscle and IGF-I resistance in obesity and NIDDM","volume":"39","author":"Dohm","year":"1990","journal-title":"Diabetes"},{"issue":"3","key":"10.1016\/j.ghir.2026.101719_bb0255","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1056\/NEJM198707163170303","article-title":"Short-term metabolic effects of recombinant human insulin-like growth factor I in healthy adults","volume":"317","author":"Guler","year":"1987","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.ghir.2026.101719_bb0260","doi-asserted-by":"crossref","first-page":"4299","DOI":"10.1210\/jc.2015-2070","article-title":"Tissue IGF-I measured by microdialysis reflects body glucose utilization after rhIGF-I injection in type 1 diabetes","volume":"100","author":"Ekstr\u00f6m","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2026.101719_bb0265","doi-asserted-by":"crossref","DOI":"10.1155\/2009\/818945","article-title":"Cross\u2010talk between PPAR\u03b3 and insulin signaling and modulation of insulin sensitivity","volume":"2009","author":"Leonardini","year":"2009","journal-title":"PPAR Res."},{"issue":"12","key":"10.1016\/j.ghir.2026.101719_bb0270","doi-asserted-by":"crossref","first-page":"5434","DOI":"10.1128\/MCB.24.12.5434-5446.2004","article-title":"Suppressor of cytokine signaling 1 (SOCS-1) and SOCS-3 cause insulin resistance through inhibition of tyrosine phosphorylation of insulin receptor substrate proteins by discrete mechanisms","volume":"24","author":"Ueki","year":"2004","journal-title":"Mol. Cell. Biol."},{"issue":"Suppl B","key":"10.1016\/j.ghir.2026.101719_bb0275","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S1096-6374(99)80081-1","article-title":"Insulin-like growth factor-I deficiency caused by a partial deletion of the IGF-I gene: effects of rhIGF-I therapy","volume":"9","author":"Camacho-H\u00fcbner","year":"1999","journal-title":"Growth Hormon. IGF Res."},{"issue":"2","key":"10.1016\/j.ghir.2026.101719_bb0280","first-page":"61","article-title":"Metabolic status of children with growth hormone insensitivity syndrome and responses to treatment with IGF-I","volume":"50","author":"Brain","year":"1998","journal-title":"Horm. Res."},{"key":"10.1016\/j.ghir.2026.101719_bb0285","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ghir.2015.08.004","article-title":"Fifty seven years of follow-up of the Israeli cohort of Laron syndrome patients-from discovery to treatment","volume":"28","author":"Laron","year":"2016","journal-title":"Growth Horm IGF Res."},{"issue":"3","key":"10.1016\/j.ghir.2026.101719_bb0290","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1159\/000339158","article-title":"Postprandial hyperglycemia corrected by IGF-I (Increlex\u00ae) in Laron syndrome","volume":"78","author":"Latrech","year":"2012","journal-title":"Horm. Res. Paediatr."}],"container-title":["Growth Hormone & IGF Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096637426000419?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096637426000419?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T21:24:19Z","timestamp":1782854659000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096637426000419"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":58,"alternative-id":["S1096637426000419"],"URL":"https:\/\/doi.org\/10.1016\/j.ghir.2026.101719","relation":{},"ISSN":["1096-6374"],"issn-type":[{"value":"1096-6374","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Real world data on rhIGF-1 therapy in children with severe primary IGF-I deficiency \u2013 The European experience","name":"articletitle","label":"Article Title"},{"value":"Growth Hormone & IGF Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ghir.2026.101719","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101719"}}